Table 1 Demographic characteristics of SOL-INCA target population stratified by cardiovascular risk groups based on C-reactive protein levels (mg/L)
From: Methylation risk score of C-reactive protein associates sleep health with related health outcomes
Overall (n = 2221) | Low risk (<1) (n = 456) | Borderline (1-3) (n = 849) | Elevated risk (>3) (n = 916) | |
|---|---|---|---|---|
Age (Mean (SD)) | 56.66 (7.56) | 56.77 (7.81) | 56.57 (7.52) | 56.69 (7.49) |
BMI (Mean (SD)) | 30.23 (5.63) | 26.86 (3.85) | 29.38 (4.79) | 32.70 (5.99) |
Sex (%) - Female | 1435 (64.6) | 227 (49.8) | 520 (61.2) | 688 (75.1) |
CRP (mg/L) (Mean (SD)) | 4.32 (9.13) | 0.60 (0.21) | 1.87 (0.57) | 8.44 (13.13) |
Background (%) | ||||
Central American | 214 (9.6) | 44 (9.6) | 78 (9.2) | 92 (10.0) |
Cuban | 380 (17.1) | 70 (15.4) | 126 (14.8) | 184 (20.1) |
Dominican | 241 (10.9) | 49 (10.7) | 93 (11.0) | 99 (10.8) |
Mexican | 754 (33.9) | 178 (39.0) | 313 (36.9) | 263 (28.7) |
Puerto Rican | 41 (1.8) | 6 (1.3) | 19 (2.2) | 16 (1.7) |
South American | 432 (19.5) | 77 (16.9) | 156 (18.4) | 199 (21.7) |
Sleep traits (mean (SD)) | ||||
REI | 8.16 (12.30) | 6.11 (9.48) | 7.41 (11.07) | 9.94 (14.32) |
Min SpO2 | 85.75 (6.55) | 86.67 (6.04) | 86.26 (6.17) | 84.78 (7.03) |
Average SpO2 | 96.29 (0.93) | 96.46 (0.77) | 96.34 (0.88) | 96.15 (1.03) |
% Time SpO2 < 90 | 1.03 (3.11) | 0.69 (1.96) | 0.88 (3.01) | 1.36 (3.62) |
ESS | 6.07 (5.06) | 5.95 (4.96) | 5.94 (4.90) | 6.25 (5.24) |
WHIIRS | 7.96 (5.51) | 7.52 (5.53) | 7.78 (5.34) | 8.35 (5.63) |
Sleep Duration (Mean (SD)) | 7.80 (1.42) | 7.70 (1.33) | 7.79 (1.33) | 7.85 (1.53) |
Comorbidities (%) | ||||
Diabetes | 678 (30.5) | 101 (22.1) | 235 (27.7) | 342 (37.3) |
Hypertension | 988 (44.5) | 163 (35.7) | 367 (43.2) | 458 (50.0) |
Cognitive traits (Mean (SD)) | ||||
Global Cognitive Baseline | 0.06 (0.74) | 0.06 (0.71) | 0.07 (0.76) | 0.06 (0.74) |
Global Cognitive Change | −0.18 (0.54) | −0.14 (0.53) | −0.19 (0.54) | −0.18 (0.55) |
